Latest
industry research report on: Thyroid Cancer Market : Industry Size,
Share, Research, Reviews, Analysis, Strategies, Demand, Growth,
Segmentation, Parameters, Forecasts
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thyroid Cancer Pipeline Review, H1 2017, provides an overview of the Thyroid Cancer (Oncology) pipeline landscape.
Thyroid
cancer is a cancer that starts in the thyroid gland. Symptoms include
lump that can be felt through the skin on neck, difficulty swallowing,
pain in neck and throat and swollen lymph nodes in neck. Predisposing
factors include female, high levels of radiation and inherited genetic
syndromes. Treatment includes surgery and thyroid hormone therapy.
Report Highlights
Global
Markets Direct's Pharmaceutical and Healthcare latest pipeline guide
Thyroid Cancer Pipeline Review, H1 2017, provides comprehensive
information on the therapeutics under development for Thyroid Cancer
(Oncology), complete with analysis by stage of development, drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest
news and press releases.
The
Thyroid Cancer (Oncology) pipeline guide also reviews of key players
involved in therapeutic development for Thyroid Cancer and features
dormant and discontinued projects. The guide covers therapeutics under
Development by Companies /Universities /Institutes, the molecules
developed by Companies in Pre-Registration, Phase III, Phase II, Phase
I, IND/CTA Filed, Preclinical and Discovery stages are 1, 3, 29, 21, 1,
10 and 2 respectively. Similarly, the Universities portfolio in
Preclinical and Discovery stages comprises 3 and 5 molecules,
respectively.
Thyroid
Cancer (Oncology) pipeline guide helps in identifying and tracking
emerging players in the market and their portfolios, enhances decision
making capabilities and helps to create effective counter strategies to
gain competitive advantage. The guide is built using data and
information sourced from Global Markets Directs proprietary databases,
company/university websites, clinical trial registries, conferences, SEC
filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources.
Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Thyroid Cancer (Oncology).
-
The pipeline guide reviews pipeline therapeutics for Thyroid Cancer
(Oncology) by companies and universities/research institutes based on
information derived from company and industry-specific sources.
-
The pipeline guide covers pipeline products based on several stages of
development ranging from pre-registration till discovery and undisclosed
stages.
-
The pipeline guide features descriptive drug profiles for the pipeline
products which comprise, product description, descriptive licensing and
collaboration details, R&D brief, MoA & other developmental
activities.
-
The pipeline guide reviews key companies involved in Thyroid Cancer
(Oncology) therapeutics and enlists all their major and minor projects.
-
The pipeline guide evaluates Thyroid Cancer (Oncology) therapeutics
based on mechanism of action (MoA), drug target, route of administration
(RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Thyroid Cancer (Oncology)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
-
Recognize emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Thyroid Cancer (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
-
Formulate corrective measures for pipeline projects by understanding
Thyroid Cancer (Oncology) pipeline depth and focus of Indication
therapeutics.
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope.
-
Adjust the therapeutic portfolio by recognizing discontinued projects
and understand from the know-how what drove them from pipeline.
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time
and money for our clients. We are a one stop solution for all your
research needs, our main offerings are syndicated research reports,
custom research, subscription access and consulting services. We serve
all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
No comments:
Post a Comment